Ocular Therapeutix (OCUL)
(Delayed Data from NSDQ)
$9.11 USD
+0.17 (1.90%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $9.12 +0.01 (0.11%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth F Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/05/2024
Time: -- |
9/2024 | $-0.23 | 0.00% |
Earnings Summary
For their last quarter, Ocular Therapeutix (OCUL) reported earnings of -$0.24 per share, missing the Zacks Consensus Estimate of -$0.22 per share. This reflects a negative earnings surprise of 9.09%. Look out for OCUL's next earnings release expected on November 05, 2024. For the next earning release, we expect the company to report earnings of -$0.23 per share, reflecting a year-over-year increase of 54.9%.
Earnings History
Price & Consensus
Zacks News for OCUL
Ocular Therapeutix (OCUL) Reports Q2 Loss, Tops Revenue Estimates
OCUL: What are Zacks experts saying now?
Zacks Private Portfolio Services